Main session


Friday January 22, morning

  08.30     Lower Limb Occlusive Disease - Session endorsed by the
  Chairmen     Alan Dardik, Koen Deloose, Yann Gouëffic, Peter Schneider
        What you need to know to perform successful peripheral repair
  08.30     Why duplex scans should be mastered by vascular surgeons, Enrico Ascher
  08.40     Drug eluted balloons. Concepts, products and how to use them, George Papandreou
  08.50     After one year, what are the results of DES? Koon Keirse
  09.00     Drug coated balloons. What are the specificities and clinical results, Frank Vermassen
  09.10     In stent restenosis: is DCB the ultimate tool? Giovanni Torsello
  09.20     What does "stent’s radial force" mean? Marc Bosiers
  09.30     DES: what happen after 5 years. Are DES still better than bare stents? Michael Dake
  09.40     DES versus recent bare stents: is the drug more efficient than a placebo? Yann Gouëffic
  09.50     Discussion
  10.00     Break in the exhibition hall
  10.30     Challenges in Lower Limb Endovascular Repair: How to Break the Limits
  Chairman     Ali Amin, Michael Dake, Eric Ducasse, Peter Goverde
  10.30     One day surgery for endovascular repair: basic requirements and patient’s selection. US experience,
Peter Schneider
  10.40     SFA long lesions: which one can be treated endo and how? Koen Deloose
  10.50     BTK lesions: DEB or DES? Roberto Ferraresi
  11.00     Tibial arteries repair: when and how, Peter Schneider
  11.10     What can be expected of tibial repair in diabetic patients, Daniel Brandao
  11.20     Ankle approaches: material, techniques and some results, Roberto Ferraresi
  11.30     Is there a role for distal bypass in the endovascular era: lessons learnt from 15.000 procedures,
Clement Darling
  11.40     Bypass in the leg after failed endo repair. Do the results compare to first line bypass? Julien Sfeir
  11.50     Follow-up of patients treated by prosthetic bypass of the lower limb, cost model evaluation at two years, Yann Gouëffic
  12.00     Discussion
  12.05     Industry symposia
  13.05     Lunch in the exhibition hall

Main session 1


Friday January 22, afternoon

  14.00     Aortic Occlusive Disease
& experts
    Martin Malina, Gustavo Oderich, Grzegorz Oszkinis, Giovanni Torsello
        Duel. Totally occluded aorta
  14.00     Open surgery is the norm, Myke Wyatt
  14.10     Open surgery is a major and unnecessary aggression, Martin Malina
  14.20     Discussion
  14.40     Landscape of error in aortic procedure, Colin Bicknell
  14.50     Mistakes can have a heavy toll. What you must know to avoid defeat, Isabelle Lucas Baloup
  15.00     Discussion
  15.10     Cases selected by Jean-Pierre Becquemin for world experts opinion
  15.40     Carotid - PART I
  15.40     Not all stenoses are at risk of stroke. Which ones should not be missed?
Stavros Kakkos
        Duel. There is no need for a new trial comparing intervention and medical treatment for carotid stenoses
  15.50     For the motion, Réda Hassen-Khodja
  16.00     Against the motion, Jean-Louis Mas
  16.10     Discussion
  16.20     Break in the exhibition hall
  16.50     Carotid - PART II
  Chairmen     Mohamed Bouayed, Hans-Henning Eckstein, Michel Makaroun, Ross Naylor
  16.50     ACST 2: 2.000 patients randomized. What are the lessons? Alison Halliday
  17.00     Is plaque morphology a predictor of neurological complication after CAS or CEA? Wesley Moore
  17.10     Discussion
  17.20     Honor guest lecture. The lost tribe, Ross Naylor
        Some tricks to improve CAS results
  17.30     The use of advanced imaging tools, Koen Deloose
  17.40     The use of proximal protection and mesh covered stents, Peter Schneider
  17.50     Can CAS improve cognitive function? Christos Liapis
  18.00     Discussion
        How to improve CEA
  18.10     By using simple but often ignored rules, Carlo Pratesi
  18.20     Surgery is safe after an acute stroke, Gustav Fraedrich
  18.40     Discussion
  19.00     End of the session

Main session 2


Friday January 22, afternoon

  14.00     Flash news. The Latest of EVAR Technology
  Chairmen     Alan Dardik, Pascal Desgranges, Roger Greenhalgh, Willem Wisselink
  14.00     PTFe grafts, Marc Van Sambeek
  14.10     Do low profile grafts compromise durability? Sonia Ronchey
  14.20     5 year results of a new generation device, Michel Makaroun
  14.30     Why stopping the follow up put your patients at risk? Michel Bartoli
  14.40     How do the French Engage study compared with international registry? Maxime Raux
  14.50     Discussion
  15.00     Ruptured AAA - Session endorsed by the
        Duel. Is the debate about ruptured aneurysms treatment over?
  15.00     Open surgery is as good as endo: lessons from IMPROVE trial, Janet Powell
  15.10     Forget the knife: EVAR is a most valuable option in all ruptures, Frank Veith
  15.20     Discussion
  15.30     Local anesthesia for ruptured AAA. One key to improve survival? Jan Heyligers
  15.40     Standard EVAR is not applicable in all rupture cases: what are my tricks to treat 100% rupture cases endo? Mario Lachat
  15.50     Discussant, Claude Angel
  15.55     Open repair for rupture: recent tricks which have improved the results, Adel Khayati
  16.05     Discussion
  16.10     Break in the exhibition hall
  16.40     How Can We Improve the Results of EVAR
  Chairmen     Eric Allaire, Clement Darling, Ian Loftus, Fabio Verzini
        The dead space in AAA sac is the ultimate enemy
  16.40     Concept and new graft design to overcome the issue, Fabien Koskas
  16.50     EVAS: any doubt left after more than 300 procedures and the European register? Ian Loftus
  17.00     Discussion
        How to improve results and cost of EVAR
  17.10     Preoperative use of an electronic simulator, Jean-Nöel Albertini
  17.20     Hypnosis for endovascular interventions: an overview, Véronique Mercier
  17.27     Hypnosis for EVAR: it works! Can you believe it? Asmaa Khaled
  17.35     Fascia suture is cheaper than preclosing device but is it as safe? Thomas Larzon
  17.45     Can endostappling improve the results of EVAR? Jean-Paul de Vries
  17.55     Thrombus lining in an EVAR stent graft: is it harmful, should it be treated? Hence Verhagen
  18.05     Appraisal of current societies guidelines to follow all EVAR patients, Roger Greenhalgh
  18.15     Why stopping the follow up put your patients at risk, Michel Bartoli
  18.25     What are the specific requirements and results of EVAR in Japanese patients? Kimihiro Komori
  18.35     Discussion
  18.45     New tools for clinical research studies, Fabien Leclercq
  18.55     End of the session
      Simultaneous translation : Headphones will be available on request (only if a valid ID is presented) when entering the room.